[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fkfPfEmxUVAVA79RTDsAYwN3SXJqtSzqQhnD66AeyeJE":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":8,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":32,"phaseBuckets":33,"rows":40},"Ullevaal University Hospital",[4],77,false,0,11,14707,55,[13,16,18,21,23,25,27,30],{"name":14,"count":15},"Pain, Postoperative",4,{"name":17,"count":15},"Femoral Neck Fractures",{"name":19,"count":20},"Postoperative Pain",3,{"name":22,"count":20},"Quality of Life",{"name":24,"count":20},"Hip Osteoarthritis",{"name":26,"count":20},"Low Back Pain",{"name":28,"count":29},"Hysterectomy",2,{"name":31,"count":29},"Multiple Myeloma",[],[34,35,36,37,38,39],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[41,84,103,121,139,157,175,201,219,237,264,282,300,327,345,373,391,422,440,458,476,494,512,539,557,575,600,626,644,662,680,705,730,756,782,806,831,849,872,897,921,945,970],{"intervention":42,"totalTrials":29,"cells":43},"Paracetamol (acetaminophen) 1000 mg",{"EARLY_PHASE1":44,"PHASE1":46,"PHASE2":48,"PHASE3":50,"PHASE4":52,"NA":82},{"trials":45,"activeCount":8},[],{"trials":47,"activeCount":8},[],{"trials":49,"activeCount":8},[],{"trials":51,"activeCount":8},[],{"trials":53,"activeCount":8},[54,70],{"nctId":55,"briefTitle":56,"status":57,"phases":58,"primaryCompletion":59,"completion":59,"start":60,"enrollment":61,"conditions":62,"interventions":64},"NCT00699114","Analgesic Effect of Ibuprofen, Paracetamol (Acetaminophen), and Paracetamol (Acetaminophen) Plus Codeine on Acute Pain","COMPLETED",[38],"2009-12","2007-06",350,[63],"Surgery",[65,66,67,68,42,69],"Ibuprofen 400 mg","Ibuprofen 600 mg","Ibuprofen 800 mg","Paracetamol (acetaminophen) 500 mg","Paracetamol (acetaminophen) 1000 mg + codeine 60 mg",{"nctId":71,"briefTitle":72,"status":57,"phases":73,"primaryCompletion":74,"completion":74,"start":75,"enrollment":76,"conditions":77,"interventions":79},"NCT00921505","Effect of Ibuprofen, Paracetamol and Their Combination on Radical Oxygen Species (ROS) Production",[38],"2010-01","2009-05",7,[78],"Pain",[80,80,42,81],"Ibuprofen","Paracetamol + ibuprofen",{"trials":83,"activeCount":8},[],{"intervention":65,"totalTrials":85,"cells":86},1,{"EARLY_PHASE1":87,"PHASE1":89,"PHASE2":91,"PHASE3":93,"PHASE4":95,"NA":101},{"trials":88,"activeCount":8},[],{"trials":90,"activeCount":8},[],{"trials":92,"activeCount":8},[],{"trials":94,"activeCount":8},[],{"trials":96,"activeCount":8},[97],{"nctId":55,"briefTitle":56,"status":57,"phases":98,"primaryCompletion":59,"completion":59,"start":60,"enrollment":61,"conditions":99,"interventions":100},[38],[63],[65,66,67,68,42,69],{"trials":102,"activeCount":8},[],{"intervention":66,"totalTrials":85,"cells":104},{"EARLY_PHASE1":105,"PHASE1":107,"PHASE2":109,"PHASE3":111,"PHASE4":113,"NA":119},{"trials":106,"activeCount":8},[],{"trials":108,"activeCount":8},[],{"trials":110,"activeCount":8},[],{"trials":112,"activeCount":8},[],{"trials":114,"activeCount":8},[115],{"nctId":55,"briefTitle":56,"status":57,"phases":116,"primaryCompletion":59,"completion":59,"start":60,"enrollment":61,"conditions":117,"interventions":118},[38],[63],[65,66,67,68,42,69],{"trials":120,"activeCount":8},[],{"intervention":67,"totalTrials":85,"cells":122},{"EARLY_PHASE1":123,"PHASE1":125,"PHASE2":127,"PHASE3":129,"PHASE4":131,"NA":137},{"trials":124,"activeCount":8},[],{"trials":126,"activeCount":8},[],{"trials":128,"activeCount":8},[],{"trials":130,"activeCount":8},[],{"trials":132,"activeCount":8},[133],{"nctId":55,"briefTitle":56,"status":57,"phases":134,"primaryCompletion":59,"completion":59,"start":60,"enrollment":61,"conditions":135,"interventions":136},[38],[63],[65,66,67,68,42,69],{"trials":138,"activeCount":8},[],{"intervention":68,"totalTrials":85,"cells":140},{"EARLY_PHASE1":141,"PHASE1":143,"PHASE2":145,"PHASE3":147,"PHASE4":149,"NA":155},{"trials":142,"activeCount":8},[],{"trials":144,"activeCount":8},[],{"trials":146,"activeCount":8},[],{"trials":148,"activeCount":8},[],{"trials":150,"activeCount":8},[151],{"nctId":55,"briefTitle":56,"status":57,"phases":152,"primaryCompletion":59,"completion":59,"start":60,"enrollment":61,"conditions":153,"interventions":154},[38],[63],[65,66,67,68,42,69],{"trials":156,"activeCount":8},[],{"intervention":69,"totalTrials":85,"cells":158},{"EARLY_PHASE1":159,"PHASE1":161,"PHASE2":163,"PHASE3":165,"PHASE4":167,"NA":173},{"trials":160,"activeCount":8},[],{"trials":162,"activeCount":8},[],{"trials":164,"activeCount":8},[],{"trials":166,"activeCount":8},[],{"trials":168,"activeCount":8},[169],{"nctId":55,"briefTitle":56,"status":57,"phases":170,"primaryCompletion":59,"completion":59,"start":60,"enrollment":61,"conditions":171,"interventions":172},[38],[63],[65,66,67,68,42,69],{"trials":174,"activeCount":8},[],{"intervention":176,"totalTrials":85,"cells":177},"Morphine and oxycodone",{"EARLY_PHASE1":178,"PHASE1":180,"PHASE2":182,"PHASE3":184,"PHASE4":186,"NA":199},{"trials":179,"activeCount":8},[],{"trials":181,"activeCount":8},[],{"trials":183,"activeCount":8},[],{"trials":185,"activeCount":8},[],{"trials":187,"activeCount":8},[188],{"nctId":189,"briefTitle":190,"status":57,"phases":191,"primaryCompletion":192,"completion":192,"start":193,"enrollment":194,"conditions":195,"interventions":198},"NCT00528177","Morphine vs. Oxycodone for Postoperative Pain Management",[38],"2008-06","2007-09",90,[28,196,19,197],"Myoma","Opioids",[176],{"trials":200,"activeCount":8},[],{"intervention":80,"totalTrials":85,"cells":202},{"EARLY_PHASE1":203,"PHASE1":205,"PHASE2":207,"PHASE3":209,"PHASE4":211,"NA":217},{"trials":204,"activeCount":8},[],{"trials":206,"activeCount":8},[],{"trials":208,"activeCount":8},[],{"trials":210,"activeCount":8},[],{"trials":212,"activeCount":8},[213],{"nctId":71,"briefTitle":72,"status":57,"phases":214,"primaryCompletion":74,"completion":74,"start":75,"enrollment":76,"conditions":215,"interventions":216},[38],[78],[80,80,42,81],{"trials":218,"activeCount":8},[],{"intervention":81,"totalTrials":85,"cells":220},{"EARLY_PHASE1":221,"PHASE1":223,"PHASE2":225,"PHASE3":227,"PHASE4":229,"NA":235},{"trials":222,"activeCount":8},[],{"trials":224,"activeCount":8},[],{"trials":226,"activeCount":8},[],{"trials":228,"activeCount":8},[],{"trials":230,"activeCount":8},[231],{"nctId":71,"briefTitle":72,"status":57,"phases":232,"primaryCompletion":74,"completion":74,"start":75,"enrollment":76,"conditions":233,"interventions":234},[38],[78],[80,80,42,81],{"trials":236,"activeCount":8},[],{"intervention":238,"totalTrials":85,"cells":239},"Remifentanil",{"EARLY_PHASE1":240,"PHASE1":242,"PHASE2":244,"PHASE3":246,"PHASE4":248,"NA":262},{"trials":241,"activeCount":8},[],{"trials":243,"activeCount":8},[],{"trials":245,"activeCount":8},[],{"trials":247,"activeCount":8},[],{"trials":249,"activeCount":8},[250],{"nctId":251,"briefTitle":252,"status":57,"phases":253,"primaryCompletion":254,"completion":254,"start":255,"enrollment":256,"conditions":257,"interventions":259},"NCT00785863","Modulation of Remifentanil-induced Postinfusion Hyperalgesia",[38],"2009-04","2008-12",16,[258],"Hyperalgesia, Secondary",[238,260,261],"Ketorolac and remifentanil","Parecoxib and remifentanil",{"trials":263,"activeCount":8},[],{"intervention":260,"totalTrials":85,"cells":265},{"EARLY_PHASE1":266,"PHASE1":268,"PHASE2":270,"PHASE3":272,"PHASE4":274,"NA":280},{"trials":267,"activeCount":8},[],{"trials":269,"activeCount":8},[],{"trials":271,"activeCount":8},[],{"trials":273,"activeCount":8},[],{"trials":275,"activeCount":8},[276],{"nctId":251,"briefTitle":252,"status":57,"phases":277,"primaryCompletion":254,"completion":254,"start":255,"enrollment":256,"conditions":278,"interventions":279},[38],[258],[238,260,261],{"trials":281,"activeCount":8},[],{"intervention":261,"totalTrials":85,"cells":283},{"EARLY_PHASE1":284,"PHASE1":286,"PHASE2":288,"PHASE3":290,"PHASE4":292,"NA":298},{"trials":285,"activeCount":8},[],{"trials":287,"activeCount":8},[],{"trials":289,"activeCount":8},[],{"trials":291,"activeCount":8},[],{"trials":293,"activeCount":8},[294],{"nctId":251,"briefTitle":252,"status":57,"phases":295,"primaryCompletion":254,"completion":254,"start":255,"enrollment":256,"conditions":296,"interventions":297},[38],[258],[238,260,261],{"trials":299,"activeCount":8},[],{"intervention":301,"totalTrials":85,"cells":302},"naloxone",{"EARLY_PHASE1":303,"PHASE1":305,"PHASE2":307,"PHASE3":309,"PHASE4":311,"NA":325},{"trials":304,"activeCount":8},[],{"trials":306,"activeCount":8},[],{"trials":308,"activeCount":8},[],{"trials":310,"activeCount":8},[],{"trials":312,"activeCount":8},[313],{"nctId":314,"briefTitle":315,"status":57,"phases":316,"primaryCompletion":317,"completion":318,"start":319,"enrollment":320,"conditions":321,"interventions":323},"NCT01109511","A Comparison of Oxycodone\u002FNaloxone and Oxycodone After Laparoscopic Hysterectomy",[38],"2011-06-30","2011-07-30","2010-03-01",85,[19,322],"Opioid Induced Constipation",[301,324],"oxycodone",{"trials":326,"activeCount":8},[],{"intervention":324,"totalTrials":85,"cells":328},{"EARLY_PHASE1":329,"PHASE1":331,"PHASE2":333,"PHASE3":335,"PHASE4":337,"NA":343},{"trials":330,"activeCount":8},[],{"trials":332,"activeCount":8},[],{"trials":334,"activeCount":8},[],{"trials":336,"activeCount":8},[],{"trials":338,"activeCount":8},[339],{"nctId":314,"briefTitle":315,"status":57,"phases":340,"primaryCompletion":317,"completion":318,"start":319,"enrollment":320,"conditions":341,"interventions":342},[38],[19,322],[301,324],{"trials":344,"activeCount":8},[],{"intervention":346,"totalTrials":85,"cells":347},"aspirin",{"EARLY_PHASE1":348,"PHASE1":350,"PHASE2":352,"PHASE3":354,"PHASE4":356,"NA":371},{"trials":349,"activeCount":8},[],{"trials":351,"activeCount":8},[],{"trials":353,"activeCount":8},[],{"trials":355,"activeCount":8},[],{"trials":357,"activeCount":8},[358],{"nctId":359,"briefTitle":360,"status":57,"phases":361,"primaryCompletion":362,"completion":362,"start":363,"enrollment":364,"conditions":365,"interventions":369},"NCT00222261","Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.",[38],"2010-07","2003-04",1001,[366,367,368],"Coronary Heart Disease","Angina Pectoris","Atherosclerosis",[346,370],"clopidogrel",{"trials":372,"activeCount":8},[],{"intervention":370,"totalTrials":85,"cells":374},{"EARLY_PHASE1":375,"PHASE1":377,"PHASE2":379,"PHASE3":381,"PHASE4":383,"NA":389},{"trials":376,"activeCount":8},[],{"trials":378,"activeCount":8},[],{"trials":380,"activeCount":8},[],{"trials":382,"activeCount":8},[],{"trials":384,"activeCount":8},[385],{"nctId":359,"briefTitle":360,"status":57,"phases":386,"primaryCompletion":362,"completion":362,"start":363,"enrollment":364,"conditions":387,"interventions":388},[38],[366,367,368],[346,370],{"trials":390,"activeCount":8},[],{"intervention":392,"totalTrials":85,"cells":393},"Ketamine 0,1 mg\u002Fkg males",{"EARLY_PHASE1":394,"PHASE1":396,"PHASE2":398,"PHASE3":400,"PHASE4":402,"NA":420},{"trials":395,"activeCount":8},[],{"trials":397,"activeCount":8},[],{"trials":399,"activeCount":8},[],{"trials":401,"activeCount":8},[],{"trials":403,"activeCount":8},[404],{"nctId":405,"briefTitle":406,"status":57,"phases":407,"primaryCompletion":408,"completion":408,"start":409,"enrollment":410,"conditions":411,"interventions":414},"NCT00232492","Ketamine on Acute Pain in Females and Males",[38],"2006-11","2005-01",128,[412,413],"Mouth and Tooth Diseases","Tooth, Impacted",[392,415,416,417,418,419],"Ketamine 0,3 mg\u002Fkg males","Ketamine 0,5 mg\u002Fkg males","Ketamine 0,1 mg\u002Fkg females","Ketamine 0,3 mg\u002Fkg females","Ketamine 0,5 mg\u002Fkg females",{"trials":421,"activeCount":8},[],{"intervention":415,"totalTrials":85,"cells":423},{"EARLY_PHASE1":424,"PHASE1":426,"PHASE2":428,"PHASE3":430,"PHASE4":432,"NA":438},{"trials":425,"activeCount":8},[],{"trials":427,"activeCount":8},[],{"trials":429,"activeCount":8},[],{"trials":431,"activeCount":8},[],{"trials":433,"activeCount":8},[434],{"nctId":405,"briefTitle":406,"status":57,"phases":435,"primaryCompletion":408,"completion":408,"start":409,"enrollment":410,"conditions":436,"interventions":437},[38],[412,413],[392,415,416,417,418,419],{"trials":439,"activeCount":8},[],{"intervention":416,"totalTrials":85,"cells":441},{"EARLY_PHASE1":442,"PHASE1":444,"PHASE2":446,"PHASE3":448,"PHASE4":450,"NA":456},{"trials":443,"activeCount":8},[],{"trials":445,"activeCount":8},[],{"trials":447,"activeCount":8},[],{"trials":449,"activeCount":8},[],{"trials":451,"activeCount":8},[452],{"nctId":405,"briefTitle":406,"status":57,"phases":453,"primaryCompletion":408,"completion":408,"start":409,"enrollment":410,"conditions":454,"interventions":455},[38],[412,413],[392,415,416,417,418,419],{"trials":457,"activeCount":8},[],{"intervention":417,"totalTrials":85,"cells":459},{"EARLY_PHASE1":460,"PHASE1":462,"PHASE2":464,"PHASE3":466,"PHASE4":468,"NA":474},{"trials":461,"activeCount":8},[],{"trials":463,"activeCount":8},[],{"trials":465,"activeCount":8},[],{"trials":467,"activeCount":8},[],{"trials":469,"activeCount":8},[470],{"nctId":405,"briefTitle":406,"status":57,"phases":471,"primaryCompletion":408,"completion":408,"start":409,"enrollment":410,"conditions":472,"interventions":473},[38],[412,413],[392,415,416,417,418,419],{"trials":475,"activeCount":8},[],{"intervention":418,"totalTrials":85,"cells":477},{"EARLY_PHASE1":478,"PHASE1":480,"PHASE2":482,"PHASE3":484,"PHASE4":486,"NA":492},{"trials":479,"activeCount":8},[],{"trials":481,"activeCount":8},[],{"trials":483,"activeCount":8},[],{"trials":485,"activeCount":8},[],{"trials":487,"activeCount":8},[488],{"nctId":405,"briefTitle":406,"status":57,"phases":489,"primaryCompletion":408,"completion":408,"start":409,"enrollment":410,"conditions":490,"interventions":491},[38],[412,413],[392,415,416,417,418,419],{"trials":493,"activeCount":8},[],{"intervention":419,"totalTrials":85,"cells":495},{"EARLY_PHASE1":496,"PHASE1":498,"PHASE2":500,"PHASE3":502,"PHASE4":504,"NA":510},{"trials":497,"activeCount":8},[],{"trials":499,"activeCount":8},[],{"trials":501,"activeCount":8},[],{"trials":503,"activeCount":8},[],{"trials":505,"activeCount":8},[506],{"nctId":405,"briefTitle":406,"status":57,"phases":507,"primaryCompletion":408,"completion":408,"start":409,"enrollment":410,"conditions":508,"interventions":509},[38],[412,413],[392,415,416,417,418,419],{"trials":511,"activeCount":8},[],{"intervention":513,"totalTrials":85,"cells":514},"Ibuprofen + Paracetamol",{"EARLY_PHASE1":515,"PHASE1":517,"PHASE2":519,"PHASE3":521,"PHASE4":523,"NA":537},{"trials":516,"activeCount":8},[],{"trials":518,"activeCount":8},[],{"trials":520,"activeCount":8},[],{"trials":522,"activeCount":8},[],{"trials":524,"activeCount":8},[525],{"nctId":526,"briefTitle":527,"status":57,"phases":528,"primaryCompletion":529,"completion":530,"start":531,"enrollment":532,"conditions":533,"interventions":534},"NCT00921700","Analgesic Effect of Paracetamol, Paracetamol + Codeine, Ibuprofen and Their Combination",[38],"2014-11","2015-04","2009-06",200,[14],[513,535,536],"Ibuprofen + Paracetamol + Codeine","Paracetamol + Codeine",{"trials":538,"activeCount":8},[],{"intervention":535,"totalTrials":85,"cells":540},{"EARLY_PHASE1":541,"PHASE1":543,"PHASE2":545,"PHASE3":547,"PHASE4":549,"NA":555},{"trials":542,"activeCount":8},[],{"trials":544,"activeCount":8},[],{"trials":546,"activeCount":8},[],{"trials":548,"activeCount":8},[],{"trials":550,"activeCount":8},[551],{"nctId":526,"briefTitle":527,"status":57,"phases":552,"primaryCompletion":529,"completion":530,"start":531,"enrollment":532,"conditions":553,"interventions":554},[38],[14],[513,535,536],{"trials":556,"activeCount":8},[],{"intervention":536,"totalTrials":85,"cells":558},{"EARLY_PHASE1":559,"PHASE1":561,"PHASE2":563,"PHASE3":565,"PHASE4":567,"NA":573},{"trials":560,"activeCount":8},[],{"trials":562,"activeCount":8},[],{"trials":564,"activeCount":8},[],{"trials":566,"activeCount":8},[],{"trials":568,"activeCount":8},[569],{"nctId":526,"briefTitle":527,"status":57,"phases":570,"primaryCompletion":529,"completion":530,"start":531,"enrollment":532,"conditions":571,"interventions":572},[38],[14],[513,535,536],{"trials":574,"activeCount":8},[],{"intervention":576,"totalTrials":85,"cells":577},"Amlodipine 10 mg or Losartan 100 mg + Amlodipine 5 mg",{"EARLY_PHASE1":578,"PHASE1":580,"PHASE2":582,"PHASE3":584,"PHASE4":586,"NA":598},{"trials":579,"activeCount":8},[],{"trials":581,"activeCount":8},[],{"trials":583,"activeCount":8},[],{"trials":585,"activeCount":8},[],{"trials":587,"activeCount":8},[588],{"nctId":589,"briefTitle":590,"status":57,"phases":591,"completion":592,"start":593,"enrollment":594,"conditions":595,"interventions":597},"NCT00237588","Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)",[38],"2005-07","2004-12",25,[596],"Hypertension",[576],{"trials":599,"activeCount":8},[],{"intervention":601,"totalTrials":85,"cells":602},"Saline",{"EARLY_PHASE1":603,"PHASE1":605,"PHASE2":607,"PHASE3":609,"PHASE4":611,"NA":624},{"trials":604,"activeCount":8},[],{"trials":606,"activeCount":8},[],{"trials":608,"activeCount":8},[],{"trials":610,"activeCount":8},[],{"trials":612,"activeCount":8},[613],{"nctId":614,"briefTitle":615,"status":616,"phases":617,"primaryCompletion":618,"completion":618,"start":59,"enrollment":20,"conditions":619,"interventions":620},"NCT00921765","Reversal of Ketamine Pharmacodynamic Effects With Naloxone","TERMINATED",[38],"2017-12",[78],[601,621,622,623],"Saline + Ketamine","Naloxone + Placebo","Naloxone + Ketamine",{"trials":625,"activeCount":8},[],{"intervention":621,"totalTrials":85,"cells":627},{"EARLY_PHASE1":628,"PHASE1":630,"PHASE2":632,"PHASE3":634,"PHASE4":636,"NA":642},{"trials":629,"activeCount":8},[],{"trials":631,"activeCount":8},[],{"trials":633,"activeCount":8},[],{"trials":635,"activeCount":8},[],{"trials":637,"activeCount":8},[638],{"nctId":614,"briefTitle":615,"status":616,"phases":639,"primaryCompletion":618,"completion":618,"start":59,"enrollment":20,"conditions":640,"interventions":641},[38],[78],[601,621,622,623],{"trials":643,"activeCount":8},[],{"intervention":622,"totalTrials":85,"cells":645},{"EARLY_PHASE1":646,"PHASE1":648,"PHASE2":650,"PHASE3":652,"PHASE4":654,"NA":660},{"trials":647,"activeCount":8},[],{"trials":649,"activeCount":8},[],{"trials":651,"activeCount":8},[],{"trials":653,"activeCount":8},[],{"trials":655,"activeCount":8},[656],{"nctId":614,"briefTitle":615,"status":616,"phases":657,"primaryCompletion":618,"completion":618,"start":59,"enrollment":20,"conditions":658,"interventions":659},[38],[78],[601,621,622,623],{"trials":661,"activeCount":8},[],{"intervention":623,"totalTrials":85,"cells":663},{"EARLY_PHASE1":664,"PHASE1":666,"PHASE2":668,"PHASE3":670,"PHASE4":672,"NA":678},{"trials":665,"activeCount":8},[],{"trials":667,"activeCount":8},[],{"trials":669,"activeCount":8},[],{"trials":671,"activeCount":8},[],{"trials":673,"activeCount":8},[674],{"nctId":614,"briefTitle":615,"status":616,"phases":675,"primaryCompletion":618,"completion":618,"start":59,"enrollment":20,"conditions":676,"interventions":677},[38],[78],[601,621,622,623],{"trials":679,"activeCount":8},[],{"intervention":681,"totalTrials":85,"cells":682},"Glucosamine sulphate",{"EARLY_PHASE1":683,"PHASE1":685,"PHASE2":687,"PHASE3":689,"PHASE4":691,"NA":703},{"trials":684,"activeCount":8},[],{"trials":686,"activeCount":8},[],{"trials":688,"activeCount":8},[],{"trials":690,"activeCount":8},[],{"trials":692,"activeCount":8},[693],{"nctId":694,"briefTitle":695,"status":57,"phases":696,"primaryCompletion":697,"completion":698,"start":699,"enrollment":700,"conditions":701,"interventions":702},"NCT00404079","The Glucosamine-study: The Effect of Glucosamine in Treatment of Chronic Low Back Pain",[38],"2009-08","2010-11","2006-12",250,[26],[681],{"trials":704,"activeCount":8},[],{"intervention":706,"totalTrials":85,"cells":707},"misoprostol and cervical ripening",{"EARLY_PHASE1":708,"PHASE1":710,"PHASE2":712,"PHASE3":714,"PHASE4":726,"NA":728},{"trials":709,"activeCount":8},[],{"trials":711,"activeCount":8},[],{"trials":713,"activeCount":8},[],{"trials":715,"activeCount":8},[716],{"nctId":717,"briefTitle":718,"status":57,"phases":719,"completion":720,"start":721,"enrollment":722,"conditions":723,"interventions":725},"NCT00363389","Hysteroscopy and Misoprostol Project",[37],"2007-05","2006-09",86,[724],"Uterine Hemorrhage",[706],{"trials":727,"activeCount":8},[],{"trials":729,"activeCount":8},[],{"intervention":731,"totalTrials":85,"cells":732},"Riboflavin\u002Fdextran eyedrops",{"EARLY_PHASE1":733,"PHASE1":735,"PHASE2":737,"PHASE3":739,"PHASE4":752,"NA":754},{"trials":734,"activeCount":8},[],{"trials":736,"activeCount":8},[],{"trials":738,"activeCount":8},[],{"trials":740,"activeCount":8},[741],{"nctId":742,"briefTitle":743,"status":744,"phases":745,"primaryCompletion":746,"completion":74,"start":747,"enrollment":748,"conditions":749,"interventions":751},"NCT00435799","Evaluating Collagen Cross-Linking (CCL) Treatment in Norway","UNKNOWN",[36,37],"2009-01","2007-02",40,[750],"Keratoconus",[731],{"trials":753,"activeCount":8},[],{"trials":755,"activeCount":8},[],{"intervention":757,"totalTrials":85,"cells":758},"etoricoxib",{"EARLY_PHASE1":759,"PHASE1":761,"PHASE2":763,"PHASE3":765,"PHASE4":778,"NA":780},{"trials":760,"activeCount":8},[],{"trials":762,"activeCount":8},[],{"trials":764,"activeCount":8},[],{"trials":766,"activeCount":8},[767],{"nctId":768,"briefTitle":769,"status":57,"phases":770,"completion":771,"start":772,"enrollment":773,"conditions":774,"interventions":777},"NCT00373464","Etoricoxib for Routine Post-operative Pain Prophylaxis in Laparoscopic Surgery",[37],"2007-03","2006-03",126,[28,775,776,19],"Tubal Excision","Ovariectomy",[757],{"trials":779,"activeCount":8},[],{"trials":781,"activeCount":8},[],{"intervention":783,"totalTrials":85,"cells":784},"Misoprostol",{"EARLY_PHASE1":785,"PHASE1":787,"PHASE2":789,"PHASE3":791,"PHASE4":802,"NA":804},{"trials":786,"activeCount":8},[],{"trials":788,"activeCount":8},[],{"trials":790,"activeCount":8},[],{"trials":792,"activeCount":8},[793],{"nctId":794,"briefTitle":795,"status":57,"phases":796,"primaryCompletion":75,"completion":75,"start":797,"enrollment":798,"conditions":799,"interventions":801},"NCT00572819","Hysteroscopy After Pretreatment With Misoprostol and Estradiol Trial",[37],"2008-01",100,[800],"Cervical Ripening",[783],{"trials":803,"activeCount":8},[],{"trials":805,"activeCount":8},[],{"intervention":807,"totalTrials":85,"cells":808},"dexmedetomidine",{"EARLY_PHASE1":809,"PHASE1":811,"PHASE2":813,"PHASE3":815,"PHASE4":827,"NA":829},{"trials":810,"activeCount":8},[],{"trials":812,"activeCount":8},[],{"trials":814,"activeCount":8},[],{"trials":816,"activeCount":8},[817],{"nctId":818,"briefTitle":819,"status":744,"phases":820,"primaryCompletion":821,"completion":821,"start":822,"enrollment":748,"conditions":823,"interventions":825},"NCT01091818","Dexmedetomidine Versus Midazolam for Intensive Care Sedation of Children",[37],"2011-10","2010-03",[824],"Sedation",[807,826],"Midazolam",{"trials":828,"activeCount":8},[],{"trials":830,"activeCount":8},[],{"intervention":826,"totalTrials":85,"cells":832},{"EARLY_PHASE1":833,"PHASE1":835,"PHASE2":837,"PHASE3":839,"PHASE4":845,"NA":847},{"trials":834,"activeCount":8},[],{"trials":836,"activeCount":8},[],{"trials":838,"activeCount":8},[],{"trials":840,"activeCount":8},[841],{"nctId":818,"briefTitle":819,"status":744,"phases":842,"primaryCompletion":821,"completion":821,"start":822,"enrollment":748,"conditions":843,"interventions":844},[37],[824],[807,826],{"trials":846,"activeCount":8},[],{"trials":848,"activeCount":8},[],{"intervention":850,"totalTrials":85,"cells":851},"fentanyl",{"EARLY_PHASE1":852,"PHASE1":854,"PHASE2":856,"PHASE3":858,"PHASE4":868,"NA":870},{"trials":853,"activeCount":8},[],{"trials":855,"activeCount":8},[],{"trials":857,"activeCount":8},[],{"trials":859,"activeCount":8},[860],{"nctId":861,"briefTitle":862,"status":57,"phases":863,"completion":864,"start":865,"enrollment":798,"conditions":866,"interventions":867},"NCT00241332","Postoperative Pain After Orthopedic Surgery: Does it Help to Give Fentanyl Before Start of Remifentanil Based Anesthesia?",[37],"2006-07","2005-10",[14],[850],{"trials":869,"activeCount":8},[],{"trials":871,"activeCount":8},[],{"intervention":873,"totalTrials":85,"cells":874},"Candesartan Cilexetil",{"EARLY_PHASE1":875,"PHASE1":877,"PHASE2":879,"PHASE3":881,"PHASE4":893,"NA":895},{"trials":876,"activeCount":8},[],{"trials":878,"activeCount":8},[],{"trials":880,"activeCount":8},[],{"trials":882,"activeCount":8},[883],{"nctId":884,"briefTitle":885,"status":57,"phases":886,"primaryCompletion":887,"completion":887,"start":888,"enrollment":889,"conditions":890,"interventions":892},"NCT00120003","Scandinavian Candesartan Acute Stroke Trial (SCAST)",[37],"2010-09","2005-06",2500,[891],"Stroke",[873],{"trials":894,"activeCount":8},[],{"trials":896,"activeCount":8},[],{"intervention":898,"totalTrials":85,"cells":899},"Pegylated Interferon alfa 2b and ribavirin",{"EARLY_PHASE1":900,"PHASE1":902,"PHASE2":904,"PHASE3":906,"PHASE4":917,"NA":919},{"trials":901,"activeCount":8},[],{"trials":903,"activeCount":8},[],{"trials":905,"activeCount":8},[],{"trials":907,"activeCount":8},[908],{"nctId":909,"briefTitle":910,"status":57,"phases":911,"completion":721,"start":912,"enrollment":913,"conditions":914,"interventions":916},"NCT00308048","14 vs 24 Weeks HCV Treatment to Genotype 2\u002F3 Patients With Rapid Virological Response",[37],"2004-03",435,[915],"Hepatitis C Virus Infection",[898],{"trials":918,"activeCount":8},[],{"trials":920,"activeCount":8},[],{"intervention":922,"totalTrials":85,"cells":923},"bupivacain",{"EARLY_PHASE1":924,"PHASE1":926,"PHASE2":928,"PHASE3":939,"PHASE4":941,"NA":943},{"trials":925,"activeCount":8},[],{"trials":927,"activeCount":8},[],{"trials":929,"activeCount":8},[930],{"nctId":931,"briefTitle":932,"status":57,"phases":933,"primaryCompletion":720,"completion":720,"start":934,"enrollment":935,"conditions":936,"interventions":938},"NCT00804674","Pain Study Using Intermittent Bupivacain Injections After Breast Reconstruction With DIEP Flap",[36],"2005-08",47,[937],"Breast Reconstruction",[922],{"trials":940,"activeCount":8},[],{"trials":942,"activeCount":8},[],{"trials":944,"activeCount":8},[],{"intervention":946,"totalTrials":85,"cells":947},"triamcinolone and lidocaine hydrochloride",{"EARLY_PHASE1":948,"PHASE1":950,"PHASE2":952,"PHASE3":954,"PHASE4":956,"NA":958},{"trials":949,"activeCount":8},[],{"trials":951,"activeCount":8},[],{"trials":953,"activeCount":8},[],{"trials":955,"activeCount":8},[],{"trials":957,"activeCount":8},[],{"trials":959,"activeCount":8},[960],{"nctId":961,"briefTitle":962,"status":57,"phases":963,"primaryCompletion":964,"completion":699,"start":965,"enrollment":966,"conditions":967,"interventions":969},"NCT00640575","Subacromial Ultrasound-guided or Systemic Steroid Injection for Rotator Cuff Disease, a Randomized Double Blinded Study",[39],"2006-10","2005-03",106,[968],"Rotator Cuff Disease",[946,946],{"intervention":971,"totalTrials":85,"cells":972},"levosimendan",{"EARLY_PHASE1":973,"PHASE1":975,"PHASE2":977,"PHASE3":979,"PHASE4":981,"NA":983},{"trials":974,"activeCount":8},[],{"trials":976,"activeCount":8},[],{"trials":978,"activeCount":8},[],{"trials":980,"activeCount":8},[],{"trials":982,"activeCount":8},[],{"trials":984,"activeCount":8},[985],{"nctId":986,"briefTitle":987,"status":616,"phases":988,"primaryCompletion":255,"completion":255,"start":989,"enrollment":990,"conditions":991,"interventions":994},"NCT01221116","Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery",[39],"2003-01",23,[992,993],"Heart Failure","Cardiac Surgery",[971]]